Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pradeep Singh Cheema

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Open Biology|June 8, 2021
Exploring the therapeutic potential of forkhead box O for outfoxing COVID-19Pradeep Singh Cheema, Deeptashree Nandi, Alo Nag
Carcinogenesis|June 23, 2022
The anaphase-promoting complex/cyclosome co-activator, Cdh1, is a novel target of human papillomavirus 16 E7 oncoprotein in cervical oncogenesisNeha Jaiswal, Deeptashree Nandi, Pradeep Singh Cheema, et al.
Seminars in Cancer Biology|September 1, 2017
FoxM1: Repurposing an oncogene as a biomarkerDeeptashree Nandi, Pradeep Singh Cheema, Neha Jaiswal, et al.
Frontiers in Oncology|December 13, 2021
Artemisinin Mediates Its Tumor-Suppressive Activity in Hepatocellular Carcinoma Through Targeted Inhibition of FoxM1Deeptashree Nandi, Pradeep Singh Cheema, Aakriti Singal, et al.
Scientific Reports|January 19, 2022
Repurposing the Pathogen Box compounds for identification of potent anti-malarials against blood stages of Plasmodium falciparum with PfUCHL3 inhibitory activityHina Bharti, Aakriti Singal, Manisha Saini, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
PARP1 Suppression Drives ROS Resistance in Aneuploid Cancer CellsPan Cheng, Angela Mermerian-Baghdassarian, Yufeng Wang, et al.
Molecular Cell|May 1, 2026
PARP1 suppression drives ROS resistance in aneuploid cancer cellsPan Cheng, Angela Mermerian-Baghdassarian, Yufeng Wang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Open Biology|June 8, 2021
Exploring the therapeutic potential of forkhead box O for outfoxing COVID-19Pradeep Singh Cheema, Deeptashree Nandi, Alo Nag
Carcinogenesis|June 23, 2022
The anaphase-promoting complex/cyclosome co-activator, Cdh1, is a novel target of human papillomavirus 16 E7 oncoprotein in cervical oncogenesisNeha Jaiswal, Deeptashree Nandi, Pradeep Singh Cheema, et al.
Seminars in Cancer Biology|September 1, 2017
FoxM1: Repurposing an oncogene as a biomarkerDeeptashree Nandi, Pradeep Singh Cheema, Neha Jaiswal, et al.
Frontiers in Oncology|December 13, 2021
Artemisinin Mediates Its Tumor-Suppressive Activity in Hepatocellular Carcinoma Through Targeted Inhibition of FoxM1Deeptashree Nandi, Pradeep Singh Cheema, Aakriti Singal, et al.
Scientific Reports|January 19, 2022
Repurposing the Pathogen Box compounds for identification of potent anti-malarials against blood stages of Plasmodium falciparum with PfUCHL3 inhibitory activityHina Bharti, Aakriti Singal, Manisha Saini, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
PARP1 Suppression Drives ROS Resistance in Aneuploid Cancer CellsPan Cheng, Angela Mermerian-Baghdassarian, Yufeng Wang, et al.
Molecular Cell|May 1, 2026
PARP1 suppression drives ROS resistance in aneuploid cancer cellsPan Cheng, Angela Mermerian-Baghdassarian, Yufeng Wang, et al.
Pageof 1